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The direct quantitation of active ingredients in solid pharmaceutical tablets by desorption
electrospray ionization mass spectrometry (DESI MS) is complicated by the dependence of the
DESI signal on variables such as spray angles and distances, morphological sample properties,
and the difficulty of properly incorporating an internal standard. Here, a DESI MS method for
the direct quantitative screening of widely counterfeited antimalarial tablets containing
artesunate is presented. This method is based on reactive DESI, where analyte desorption and
ionization occur by the formation of noncovalent complexes between alkylamine molecules in
the DESI spray solution and artesunate molecules exposed on the sample surface in the open
air. For quantitation purposes, the internal standard d4-artesunic acid was synthesized by
esterification of d4-succinic anhydride and dihydroartemisinin, and homogeneously dispersed
on the tablet surface via a controlled deposition procedure. The analyte-to-internal standard
signal intensity ratio was observed to be largely independent of all DESI variables, only
showing dependence on tablet hardness. Analysis of artesunate tablet standards prepared
with known amounts of the active ingredient in the 0.02 to 0.32 mg artesunate mg 1 tablet
range resulted in a calibration curve with good linearity (r  0.9985). Application of this
method to the direct quantitation of genuine artesunate tablets from Vietnam showed a 6%
(n  4) precision and 94% accuracy after the spectral data were corrected for tablet
hardness. (J Am Soc Mass Spectrom 2008, 19, 380 –388) © 2008 American Society for Mass
SpectrometryTh e development of methodologies that allow thequantitative determination of physiologically activeanalytes in complex matrices is an ongoing trend in
analytical and biological mass spectrometry. In this
sense, high-performance liquid chromatography (LC)
coupled to mass spectrometry (MS) via electrospray
ionization (ESI), or atmospheric pressure chemical ion-
ization (APCI), has become the de facto routine quan-
titative analytical tool in clinical chemistry, drug dis-
covery, and proteomics [1–3]. Although LC-MS is
characterized by one of the highest peak capacities of
contemporary analytical separation methodologies
[4], alternative techniques are constantly being devel-
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doi:10.1016/j.jasms.2007.11.016oped to improve sample throughput, eliminate cross-
contamination, and increase reproducibility.
The emergence of ambient desorption ionization
techniques such as desorption electrospray ionization
(DESI) [5], direct analysis in real time (DART) [6], and
others has enabled the direct sampling of complex solid
materials in the open air with minimal or no sample
preparation. DESI makes use of a pneumatically assisted
electrospray jet, which is directed unto the sample surface
to desorb the condensed-phase analyte(s). Following de-
sorption, the analyte-containing charged droplets scat-
tered off the sample surface are sampled by a mass
spectrometer. DESI enables the analysis of materials
over a large mass range and provides the capability to
perform ion-molecule reactions at the interface between
the charged microdroplets and the condensed-phase
analytes, resulting in improved detection selectivity
and sensitivity [7]. These reactions are achieved by the
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what is now generally referred to as “reactive” DESI
[7–9].
One very promising application of DESI is the direct
screening of solid pharmaceutical formulations for drug
quality control. The majority of DESI work done in this
area thus far has been qualitative [7, 10–16]. The large
dependence of the DESI signal on various DESI param-
eters such as spray tip-to-surface distance, sample-to-
spectrometer orifice distance, spray incident angle, and
collection angle might be one of the major contributing
factors limiting progress in this direction. Fixed-geometry
DESI probes have been shown to somewhat mitigate this
problem [17]. However, in the case of pharmaceutical
solid dosage forms there is an additional dependence of
the DESI signal on sample properties such as hardness
and sample shape, the latter influencing incidence and
collection angles. In their seminal work, Cooks and
coworkers first suggested that the use of an internal
standard (IS) should enable quantitative applications,
and demonstrated the feasibility of using DESI in the
quantitative analysis of phenylalanine deposited unto
glass substrates [18]. DESI has also been applied to the
quantitative analysis of alkaloids separated by thin-
layer chromatography [19], but to the best of our
knowledge, there have been no reports where DESI is
employed for the direct quantitation of active pharma-
ceutical ingredients in solid tablets.
One major challenge faced today by public health
authorities and the pharmaceutical industry relates to
the counterfeiting of various drug formulations [20].
Due to its high cost and demand, one pharmaceutical
that has been highly counterfeited is the oral antimalar-
ial artesunate [21]. Artemisinin-derived antimalarial
drugs such as artemether, arteether, dihydroartemisi-
nin, and artesunate, as mono-therapies, or in combina-
tion with co-drugs such as lumefantine and mefloquine
are currently the only effective treatment for multidrug
resistant Plasmodium falciparum malaria [21] in many
parts of Asia and Africa. Recently discovered fake
artesunate samples have been shown to contain small
subtherapeutic quantities of the correct active ingredi-
ent, possibly introduced to defeat current colorimetric
authentication tests in use in the field [7, 22]. This is one
of the most dangerous types of fake medicines for
public health, as their widespread distribution could
favor the emergence of drug resistant parasite strains.
Hence, there is urgency for the development of rapid
screening methods to quantitatively assess the quality of
antimalarial tablets collected in the field.
Here, we exploit our previously reported qualitative
reactive DESI approach [7, 12] for the direct quantitative
analysis of artesunate tablets. Due to the challenges posed
by the incorporation of a controlled, well-dispersed
amount of IS into a solid tablet, several deposition meth-
ods are explored and compared for the development of a
quantitative analytical tool for the direct sampling of solid
antimalarial formulations. We show that the large de-
pendence of the DESI signal intensity with variousexperimental variables and sample properties can be
overcome by the homogeneous deposition and cocrys-
tallization of a deuterated IS on the tablet surface. The
method proposed here should also be applicable to the
screening of other solid dosage forms.
Experimental
Samples and Reagents
All reagents were used as received. HPLC-grade aceto-
nitrile (Fisher, Hampton, NH) and dodecylamine
(DDA; Sigma-Aldrich, St. Louis, MO) were used for
DESI and reactive DESI experiments. Ultrapure water
(18.2 M cm1) was obtained from a Nanopure purifi-
cation unit (Barnstead, San Jose, CA). Genuine artesu-
nate tablets manufactured by Mekophar Chemical
Pharmaceutical Joint-Stock Co. (Ho Chi Minh City,
Vietnam), stated to contain 50 mg of artesunate per
tablet with an average total tablet weight of 320 mg,
were used for all characterization and optimization
studies. The amount of artesunate in these samples was
also measured by liquid chromatography with spectro-
photometric detection, following the procedure de-
scribed previously [22]. Dihydroartemisinin (AApin
Chemicals Ltd., Abingdon, UK), d4-succinic anhydride,
triethylamine, tetrahydrofuran, acetic acid, anhydrous
sodium sulfate, ethylacetate, and hexane (Sigma-Al-
drich, St. Louis, MO) were used in the synthesis of
d4-artesunic acid. Cab-o-sil, talc, magnesium stearate
(Acros Organics, Morris Plains, NJ), microcrystalline
cellulose (Mallinckrodt Baker Inc., Phillipsburg, NJ),
croscarmellose sodium, and spray-dried lactose (FMC
Corp., Newark, DE) were used as excipients for the
preparation of artesunate tablet standards. Artesunic
acid (Structure 1) was purchased from AApin Chemi-
cals Ltd. All genuine and standard artesunate tablet
samples were stored at 4 °C until analyzed.Structure 1.
me 1
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The IS, d4-artesunic acid, was synthesized by the base
catalyzed esterification of dihydroartemisinin with d4-
succinic anhydride according to Scheme 1. A previously
reported procedure for the synthesis of artesunic acid
[23, 24] was followed with some modifications, using
dihydroartemisinin as the starting material. In a typical
synthetic procedure, 250 mg of dihydroartemisinin was
stirred for 2 min in 5 mL of tetrahydrofuran (THF); 125
mg of d4-succinic anhydride and 500 L of triethyl-
amine were then added to the reaction flask and stirred
for 3 h at room temperature. At the end of the reaction,
20 mL of cold water, previously adjusted to pH 4.0 with
dilute acetic acid, was added to the mixture, and the pH
finally adjusted to 4.0 by addition of dilute acetic acid.
Extraction of the reaction product was then performed
on ice using three separate 20-mL portions of 60:40
ethylacetate:hexane. The extract was washed with three
10-mL portions of chilled water previously adjusted to
pH 4.0 and then dried over anhydrous sodium sulfate.
The solvent was then evaporated in a Rotavap (30 °C) to
an estimated final volume of 5 mL, after which it was
changed by three separate additions and evaporations
of 10-mL portions of hexane. The liquid volume was
reduced to 3 mL and left to evaporate to dryness in a
hood at ambient temperatures. The crude product was
purified by recrystallization in hexane. Purity was as-
sessed by electrospray ionization MS of a 50:50 CH3CN:
H2O solution containing 1 M of the product in 100 M
DDA. The IS ESI spectrum showed predominantly a
single peak at m/z 574 corresponding to [d4  ARS 
DDA  H], indicating a high-purity reaction product,
with the expected 4 mass unit shift relative to the
artesunate standard noncovalent complex [ARS DDA
 H].
Preparation of Artesunate Tablet Standards
Artesunate tablet standards were composed of three
major constituents: excipient mixture A, spray dried
Schelactose, and artesunic acid. Excipient mixture A wascomposed of 69% microcrystalline cellulose, 1% fumed
silicon dioxide (cab-o-sil), 5% talc, 20% croscarmellose
sodium, and 5% magnesium stearate. This mixture was
prepared as follows: microcrystalline cellulose, cab-o-
sil, and croscarmellose sodium were passed through a
20 mesh sieve and mixed together in a zip-lock bag for
5 min. Talc and magnesium stearate were also passed
through the 20 mesh sieve, added to this bag, and
mixed with the other components for 2 min. Before
tablet pressing, spray dried lactose and artesunic acid
were also passed through a 20 mesh sieve and mixed
with excipient A in a zip-lock bag for 3 min. Tablets
were composed of 20% excipient A and variable
amounts of artesunic acid and spray dried lactose to
obtain tablets with variable properties such as hardness,
amount of active ingredient, diameter, and shape. Tab-
lets were pressed using a B2 rotary tablet press (Globe
Pharma, New Brunswick, NJ) at 60 rpm. Tablet hard-
ness was measured using a Monsanto hardness tester
(Tab-Machines Ltd., Bombay, India).
Desorption Electrospray Ionization Mass
Spectrometry (DESI-MS)
For quantitation purposes, all samples were treated
with 25 L of 100 mM d4-artesunic acid IS in neat
acetonitrile, unless stated otherwise. The IS solution
was kept in a 80 °C freezer at all times, and placed on
ice during use to minimize evaporation. The preferred
IS spiking method consisted of addition of the IS
solution by pipette deposition of a thin solution film
unto the surface of the samples (Figure 1). This thin film
diffuses into the sample at a rate that was observed to
be dependent on the tablet porosity. Samples were
allowed to air dry at room temperature before analysis.
This procedure is further discussed and compared with
other IS deposition approaches in the Results section.
DESI was performed using a home built DESI source
[7] at an incident angle () of 55° and a collection angle
() of 0° unless otherwise stated. Reagentless DESI was
.performed using a 75:25 CH3CN:H2O mixture. This
DESI
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for reactive DESI experiments. Except for initial com-
parative experiments, all quantitative work was per-
formed by reactive DESI. The spray solution was elec-
trically charged with an external power supply to 3
kV, and operated at a flow rate of 2 L min1, unless
stated otherwise. The nebulizer gas pressure was set to
110 psi, unless stated otherwise. All experiments were
performed on an LCQDECA XP quadrupolar ion trap
mass spectrometer (Thermo Finnegan, San Jose, CA)
auto-tuned for optimum detection of the ion of interest.
Data were collected in full scan mode via the Xcalibur
software (version 2.0, Thermo Finnegan). The ion trans-
fer capillary was set at 300 °C at a voltage of 14 V and
the tube lens voltage was 25 V. The instrument was
set to collect spectra in automatic gain mode for an ion
trap injection time of 200 ms at 2 microscans spec-
trum1. All DESI characterization experiments were
performed using genuine artesunate tablets. The assess-
ment of the effect of sample properties on the DESI
signal and the development of a calibration method
were done using artesunate tablet standards with the
same surface geometry as the genuine samples used for
characterization experiments.
Results and Discussion
To investigate the type of ionic species formed during
DESI of IS-doped genuine artesunate tablets, reagent-
less and reactive DESI analyses were first performed on
samples treated by pipette deposition, according to the
scheme depicted in Figure 1. Figure 2a shows the
reagentless DESI spectrum of an IS-pretreated genuine
artesunate tablet. In this mass spectrum, the analyte and
IS signals are spread into various species resulting in
ions at m/z 407, 411, 791, 795, and 799. These corre-
sponded to sodiated analyte and IS protonated mono-
mers and various analyte and IS protonated dimers.
Figure 1. (a) Sample pretreatment with IS: (i) p
neat acetonitrile unto the surface of sample, (ii
reactive DESI analysis of air-dried samples; (b)Various fragments could also be observed in the spec-trum as reported previously [7, 22]. The fragmentation
of analyte ions and the spread of the analyte ion signal
into various channels made it complicated to choose an
ion peak for quantitative analysis, as the relative inten-
sity of the different adducts varied between experi-
ments. Subsequent analysis of a genuine artesunate
tablet doped with IS by reactive DESI showed predom-
inantly one peak for the analyte and one for the IS with
close to two orders of magnitude improvement in signal
intensity compared to reagentless DESI (Figure 2b). This
improvement is due to stabilization of the analyte by
formation of a noncovalent complex and the consequent
bunching of the analyte intensities [7]. This approach
improved sensitivity and simplified the choice of analyte
species for further quantitative analysis.
Comparison of Internal Standard Deposition
Methods
Quantitative analysis by reactive DESI requires tablet
pretreatment with an IS. Various methods were ex-
plored for this purpose including: (i) pneumatically
assisted electrospray deposition, (ii) addition of IS di-
rectly into the DESI spray solution, and (iii) pipette
deposition of neat acetonitrile IS solution. The perfor-
mance of each of these deposition methods was as-
sessed by evaluating the temporal stability of the signal
intensity ratio of the ion at m/z 570 to that at m/z 574 at
different spray solution flow rates and positions across
the sample surface.
Nebulizer assisted electrospray deposition of IS re-
sulted in a very unstable signal intensity ratio (Figure
S1a, which can be found in the electronic version of this
article). The ratio rises very rapidly with time, suggest-
ing that this deposition method results in a very thin
coat of IS on the sample surface, but not sufficient
interdispersion with the tablet surface material. This
e deposition of a solution of d4-artesunic acid in
ing of sample after treatment with IS, and (iii)
setup showing various DESI variables.ipett
) drylayer is quickly depleted by the DESI jet, with increas-
ne in
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uniform coat of material on the sample surface, this
approach required very careful control of various vari-
ables including the nebulizer gas flow rate, the spray
tip-to-sample surface distance, and the elimination of
any air draft currents in the roomwhere the sample was
being processed. Because of these difficulties, it was
quickly realized that it would be difficult to reproduce
the amount of IS deposited on different samples, which
would translate into a poor day-to-day reproducibility.
Addition of a small amount of IS to the reactive DESI
spray solution also resulted in an unstable signal inten-
sity ratio (Figure S2b), with instabilities becoming more
prominent at higher flow rates. Because the reactive
DESI spray probes the same spot on the sample surface
over a few minutes, this spot becomes progressively
contaminated by the IS contained in the spray, which
results in a decreasing analyte-to-IS signal ratio with
time.
The method of choice adopted for these studies
involved the pipette deposition of the IS dissolved in
neat acetonitrile (Figure 1). After application of the IS,
the acetonitrile solution flows across the sample surface,
forming a homogenous liquid thin film, which is then
observed to diffuse into the sample. This process re-
quires an estimated 20 s for a genuine artesunate tablet.
No significant disintegration of the tablets was ob-
served during this process. After deposition, the sam-
ples were allowed to air dry at room temperature. For
consistency across tablets of different hardness, 30 min
Figure 2. DESI spectra of genuine artesunate
evaporation of solvent (a) reagentless DESI mod
DESI mode (spraying with 100 M dodecylamiwas allowed for this step, but we believe that furtheroptimization is possible. As several samples could be
dried in parallel, this step does not necessarily decrease
sample throughput significantly. Following IS deposi-
tion, four spots on the tablet surface were probed by
reactive DESI, one on each tablet quadrant. Reactive
DESI analysis of four surface spots required an esti-
mated 3 min per tablet with a manual x-y stage.
Reactive DESI analysis of samples spiked by this
deposition method at various solvent flow rates rang-
ing from 1 to 3 L min1 resulted in analyte and IS
ionic signals which basically tracked each other (Fig-
ure 3a), resulting in a highly stable signal intensity
ratio (Figure 3b). Similar analysis at various nebulizer
gas pressures from 100 to 200 psi resulted in an
unstable time trace when the analyte and IS signal
intensities were summed (Figure 4a), but produced a
stable signal intensity ratio at all nebulizer gas flow
rates investigated (Figure 4b). The intensity ratio was
also found to be largely stable for different positions
across the sample surface, with a relative standard
deviation of 7.9% (n  5) which suggests a homoge-
nous distribution of IS over the surface of the sample.
This ratio was also largely stable for a wide range of
DESI spray flow rate and nebulizer gas pressures,
with relative standard deviations of 5.1% (n  7) and
5.0% (n  6), respectively, as shown in Table 1. Depth
profiling of a genuine artesunate sample treated with 25
L, 100 mM IS in neat acetonitrile following the pipette
deposition method showed a stable analyte-to-IS signal
intensity ratio when the same spot on the sample was
ts pretreated with 100 mM solution of IS after
raying with 75:25 CH3CN:H2O) and (b) reactive
75:25 CH3CN:H2O).table
e (spinterrogated with the reactive DESI jet for to 60 min,
IS be
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suggests a minimum penetration of the IS up to this
depth. All subsequent experiments were performed by
Figure 3. Normalized ion intensity traces at var
intensity of ions at m/z 570 and m/z 574, (b) int
Tablets were pretreated with 25 L of 100 mM
Figure 4. Normalized ion intensity traces at
(a) Total ion intensity generated from the ions a
at m/z 570 to the ion at m/z 574. Tablets were pretreathis IS deposition method at a DESI spray solution flow
rate of 2 L min1 and a nebulizer gas pressure of 110
psi.
solution flow rates by reactive DESI. (a) Relative
ratio of the m/z 570 ion to the ion at m/z 574.
fore analysis.
us nebulizer gas pressures by reactive DESI.
/z 570 and m/z 574 (b) Intensity ratio of the ionious
ensityvario
nd mted with 25 L of 100 mM IS before analysis.
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Analyte-to-Internal Standard Signal Intensity Ratio
While DESI spray conditions can be fixed, it is difficult to
exert strict reproducible control on all the geometric settings
over long periods of time. Takáts et al. have suggested that
one possible solution is to perform the analysis in the
presence of an IS [18]. In this trend, the dependence of the
DESI signal on the various geometric parameters de-
scribing the DESI setup, including the DESI spray
tip-to-surface distance (d1), sample-to-spectrometer or-
ifice distance (x), spectrometer inlet-to-surface distance
(d2), spray incidence angle (), and droplet collection
angle (), was investigated.
Summarized in Table 1 are results of the effect of the
above-mentioned DESI variables on the analyte-to-IS
signal intensity ratio in comparison to the absolute
signal, as stated by their relative standard deviations.
For the variables  and , the relative standard devia-
tions observed for the normalized signal intensity ratio
were 11.4% (n  6) and 6.4% (n  7), as opposed to
82.1% and 72.6%, respectively, when the absolute signals
were monitored. For the variables d1, d2, and x, the
observed relative standard deviations were 10.6% (n 6),
7.8% (n 4), and 8.8% (n 6) for the signal intensity ratio
as opposed to 33.6%, 46.4% and 66.8%, respectively, for
the absolute signal. These results show lower relative
standard deviations when the analyte-to-IS signal inten-
sity ratio was monitored if compared to the sum of the
absolute signals corresponding to the analyte and IS. This
indicates a significant independence of the analyte-to-IS
intensity ratio for all DESI spray condition and geometri-
cal parameters, and suggests the potential of this approach
for the direct quantitative analysis of active ingredients in
solid pharmaceutical tablets.
Effect of Sample Properties on the
Analyte-to-Internal Standard Intensity Ratio
In our previous screening experiments of potentially
counterfeit artesunate samples collected in the field, we
observed a significant dependence of the DESI signal on
tablet hardness [7]. Is it thus important to understand
the effect of this and other sample-related variables on
Table 1. Comparison of the reproducibility of the absolute DES
DESI variables
DESI variable
Solution flow rate (1–7 L min1)
Nebulizer gas pressure (50–300 psi)
Tip-to-surface distance, d1 (1.2–6.1 mm)
Spectrometer orifice-to-surface distance, d2 (0.8–1.4 mm)
Sample-to-spectrometer orifice distance, x (2.2–7.3 mm)
Spray incident angle,  (40°90o)
Collection angle,  (0°30o)the analyte-to-IS signal intensity ratio, so as to establishcontrolled conditions under which robust quantitative
results can be obtained.
Figure 5 shows the effect of sample hardness on the
analyte-to-IS signal intensity ratio for artesunate tab-
let standards containing three different amounts of
the active ingredient. All samples were treated with
identical amounts of IS and analyzed by reactive
DESI at a spray solution flow rate of 2 L min1. An
almost linear decrease in signal intensity ratio was
observed for hardness values below 5 kg. For harder
tablets, the signal ratio becomes relatively constant,
depending primarily on the analyte concentration. As
the IS solution percolates into the sample at a rate
that depends on sample porosity, which increases
with decreasing sample hardness, the IS percolates
deeper and faster into the body of softer samples,
with the end result of a more “dilute” superficial IS
zone. This results in a larger m/z 570 to 574 signal
intensity ratio during reactive DESI analysis. For
samples prepared with hardness values larger than 5
kg, the results shown in Figure 5 suggest a quasicon-
stant degree of percolation of the IS into the tablet
body. In this case, the rate of evaporative loss of the
Figure 5. Dependence of the m/z 570 to 574 ion intensity ratio for
reactive DESI analysis of artesunate tablet standards with varying
hardness. The intensity ratios were normalized to that of the
maximum value. Tablets were pretreated with 25 L of 100 mM IS
and analyzed by reactive DESI at a solution flow rate of 2 L
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determining the amount of material migrating into
the tablet surface.
To further examine the distribution of the IS into
the tablet sample, depth profiling analysis was per-
formed at two different spray solvent rates (2 and 6
L min1) for samples prepared at three different
hardness values (2.7, 5.9, and 8.0 kg, Figure S3). At 2
L min1 the analyte-to-IS signal ratio was stable,
with relative standard deviations below 10% for all
hardness values investigated, indicating a homoge-
nous distribution of the IS within the outermost tablet
layers probed at this flow rate. Significant disintegra-
tion of the sample surface was not observed. How-
ever, if the flow rate was increased to 6 L min1, the
analyte-to-IS signal ratio was observed to gradually
increase over time. This validates our hypothesis that
a gradient of the IS is established within the tablet
surface. Tablets with different hardness showed a
different temporal evolution of the IS-to-analyte sig-
nal ratio due to differences in the rate at which the
spray ablated the surface. To ensure optimum disso-
lution properties, optimum dosage, and absorption,
pharmaceutical tablets are usually prepared with
hardness lower than 5 kg, meaning that the relative
hardness of samples and standard must be used as a
correction factor for performing quantitative DESI.
Quantitative analysis via pipette deposition of an
IS solution requires that all samples be treated with
the same amount of IS per unit tablet area. It was thus
also necessary to evaluate the change in analyte-to-IS
signal intensity ratio as a function of the surface area
treated with IS. Results observed from the reactive
DESI analysis of duplicate tablets at two different
diameters (9 and 11 mm) treated with identical
amount of IS indicate that the analyte-to-IS signal
intensity ratio increases with increasing tablet diam-
eter. The average intensity ratios of analyte-to-IS
observed for 9 mm and 11 mm diameter, 250-mg
tablets containing 50 mg artesunate were 4.5 and 7.7,
respectively. Because in both cases the analyte solu-
tion is completely dispersed over the whole tablet
surface, and the tablet thickness was kept constant, a
lower amount of IS percolated per unit surface area
when the tablet diameter was increased.
In addition to tablet diameter, the effect of tablet
shape on the analyte-to-IS signal intensity ratio was
investigated. Standard tablet samples with flat and
convex topology treated with identical amounts of IS
solution showed a negligible change in analyte-to-IS
signal intensity ratio with convex tablets showing
slightly higher ratios compared with flat ones. The
observed average percentage increase in the intensity
ratio was 9.9%. This is probably due to the larger
surface area of the convex sample, which results in a
lower amount of IS per surface area, and thus a higher
analyte-to-IS signal intensity ratio.Calibration and Direct Quantitation of Artesunate
in Pharmaceutical Samples by Reactive DESI
The large independence of the analyte-to-IS signal in-
tensity ratio observed for all DESI variables promises
applicability of reactive DESI for direct quantitative
screening. As a first step in establishing the quantitative
capabilities of the approach proposed here, a calibration
curve for the prediction of unknown samples was
generated using 250-mg tablet standards with varying
artesunate amounts, prepared at a hardness close to
that of genuine samples (2.4  0.2 kg), with a flat
surface shape, and with diameters of 9 mm (area  63.6
mm2). Three replicate tablets were prepared at each
level of the active ingredient in the range of 0.02 to 0.32
mg artesunate mg1 tablet. The calibration curve
showed good linearity over the investigated concentra-
tion range with a correlation coefficient of 0.9985. The
limit of detection defined as the analyte concentration
giving a signal equal to the blank signal plus three
standard deviations was calculated from the calibration
curve to be equal to 0.018 mg artesunate mg1 tablet
(4.5 mg/250 mg tablet). A set of test samples, with
amounts of artesunate that fell in the calibration curve
range, was prepared for validation purposes. Results
showed a good correspondence between the expected
and the predicted amounts of artesunate present in the
validation sample set, with a correlation coefficient of
0.9971, and y-intercept and slope values of 0.0109 
0.0197 and 1.139  0.108, respectively. These results
validate the applicability of this quantitative DESI MS
approach to samples with known (or constant) hard-
ness, surface area, and shape, such as those encountered
in a quality control laboratory setting.
A more challenging application of this DESI ap-
proach is the quantitation of active ingredients in sam-
ples with hardness not exactly matched to the calibra-
tion standards. This would be the case, for example, of
drugs suspected of being counterfeit, which are col-
lected in the field for further off-field forensic analysis.
As a first test of the performance of the proposed
method in this scenario, three different artesunate tablet
samples from Mekophar pharmaceutical collected in
the field with a measured hardness of 2.7  0.2 kg and
diameter of 10.1 mm were treated with IS solution and
analyzed by reactive DESI against a calibration curve
created with standard tablets with 2.4 0.2 kg hardness
and 9 mm diameter. Table 2 summarizes the results of
Table 2. Quantitation of artesunate in genuine sample by DESI
MS compared with the expected amount present in the sample







Tablet 1 73  4 58  3 53  2
Tablet 2 73  5 58  4 56  2
Tablet 3 68  4 53  3 50  2
388 NYADONG ET AL. J Am Soc Mass Spectrom 2008, 19, 380–388these analyses. An average relative standard deviation
of 6% was obtained for the predicted amount of arte-
sunate present in the three samples, which compares
relatively well with the 2% observed for HPLC analysis.
Comparison of the predicted amount of artesunate to
the amount determined by HPLC showed significant
deviations (35% on average) if uncorrected by tablet
hardness and surface area. Upon normalization of the
analyte-to-IS signal ratio by the tablet hardness and
surface area, and comparison to the standard contain-
ing 50 mg artesunate/tablet, the difference between the
artesunate amount determined by DESI and the amount
determined by HPLC was reduced to 6% on average.
This is a clear indication that the sample physical
properties play a critical role in quantitative analysis by
DESI. When corrected, the average accuracy obtained
by reactive DESI quantitation can be considered suffi-
cient for determining active ingredient content with an
acceptable degree of accuracy (94%) for a high-
throughput pharmaceutical screening assay such as
this.
Conclusions
Reactive DESI has been shown to be successful as a
high-throughput quantitative approach for the direct
screening of antimalarial tablets. The controlled depo-
sition of an internal standard makes it possible to
perform quantitative measurements independently
from the DESI setup variables. The method shows a
precision of 6% (n  4) and an accuracy of 94%, which
is largely acceptable for the rapid quantitation of active
ingredients in pharmaceutical tablets. Sample hardness
and surface area are important factors to be taken into
account when implementing this method. Although
correction schemes to take into account tablet hardness
and shape are feasible, it is preferable that, whenever
possible, the calibration sample set has the same char-
acteristics as the unknowns. Future work will be geared
towards investigating the role of charge competition
effects in DESI, in an effort towards quantifying multi-
ple components without chromatographic separation.
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